Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
W93bmj6SDt7LXPce
